Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.01% |
| 2 | Technology | 7.75% |
| 3 | Financials | 7.01% |
| 4 | Consumer Discretionary | 6.9% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
BlueLinx
BXC
$653M
| $195K | ﹤0.01% |
+22,812
| New | +$141K |
|
3802
Ocular Therapeutix
OCUL
$2.37B
| $195K | ﹤0.01% |
23,437
-992,639
| -98% | -$6.58M |
|
3803
Western New England Bancorp
WNEB
$278M
| $194K | ﹤0.01% |
+33,505
| New | +$186K |
|
|
TBHC
3804
DELISTED
The Brand House Collective
TBHC
| $193K | ﹤0.01% |
71,094
-252,361
| -78% | -$312K |
|
|
CKPT
3805
DELISTED
Checkpoint Therapeutics
CKPT
| $190K | ﹤0.01% |
9,612
+5,208
| +118% | +$94.9K |
|
|
PFC
3806
DELISTED
Premier Financial Corp. Common Stock
PFC
| $190K | ﹤0.01% |
10,725
-102,323
| -91% | -$1.66M |
|
3807
Natural Health Trends
NHTC
$15M
| $189K | ﹤0.01% |
33,083
-15,499
| -32% | -$80.2K |
|
|
WLL
3808
DELISTED
Whiting Petroleum Corporation
WLL
| $189K | ﹤0.01% |
2,233
-4,386
| -66% | -$342K |
|
|
GCAP
3809
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $188K | ﹤0.01% |
31,204
+18,312
| +142% | +$113K |
|
|
GNCA
3810
DELISTED
Genocea Biosciences, Inc.
GNCA
| $187K | ﹤0.01% |
81,385
+68,664
| +540% | +$158K |
|
3811
OFG Bancorp
OFG
$2.21B
| $186K | ﹤0.01% |
13,879
-165,573
| -92% | -$2M |
|
3812
DHI Group
DHX
$183M
| $183K | ﹤0.01% |
87,277
-125,169
| -59% | -$322K |
|
|
JFIN
3813
Jiayin Group
JFIN
$121M
| $182K | ﹤0.01% |
+46,520
| New | +$132K |
|
3814
Target Hospitality
TH
$1.78B
| $182K | ﹤0.01% |
+107,437
| New | +$208K |
|
3815
Natural Gas Services Group
NGS
$448M
| $181K | ﹤0.01% |
28,853
+13,466
| +88% | +$78.1K |
|
3816
iShares MSCI Europe Financials ETF
EUFN
$4.35B
| $180K | ﹤0.01% |
+12,626
| New | +$167K |
|
3817
Nature's Sunshine
NATR
$252M
| $180K | ﹤0.01% |
+19,956
| New | +$173K |
|
|
PRGX
3818
DELISTED
PRGX Global, Inc.
PRGX
| $180K | ﹤0.01% |
38,293
+8,638
| +29% | +$31K |
|
|
RJET
3819
Republic Airways Holdings
RJET
$879M
| $179K | ﹤0.01% |
+3,477
| New | +$184K |
|
|
NGD
3820
DELISTED
New Gold Inc
NGD
| $179K | ﹤0.01% |
132,346
+62,594
| +90% | +$62.8K |
|
3821
DNA X Inc
SONM
$4.81M
| $178K | ﹤0.01% |
+122
| New | +$195K |
|
|
ONCT
3822
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $178K | ﹤0.01% |
3,128
-136
| -4% | -$7.67K |
|
|
LAC
3823
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $178K | ﹤0.01% |
35,169
+4,373
| +14% | +$16.3K |
|
|
ACH
3824
DELISTED
Alum Corp of China Ltd
ACH
| $177K | ﹤0.01% |
+37,669
| New | +$188K |
|
3825
Adeia
ADEA
$2.9B
| $175K | ﹤0.01% |
44,725
-225,730
| -83% | -$854K |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.